Clinical trial · Interventional
Promoting Cancer Symptom Management in Older Adults
NCT03143829CI-TRIAL-00055708completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use will be examined.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy-induced Nausea and Vomiting | — | UNRESOLVED | — |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| eSSET-CINV | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- electronic Symptom Self-Management Training- CINV (eSSET-CINV) is an educational intervention administered once at the start of treatment
- interventionNames
- Other: eSSET-CINV
- type
- ACTIVE_COMPARATOR
- label
- Wait Control group
- description
- The Wait control group receives the electronic Symptom Self-Management Training- CINV (eSSET-CINV) at the last study visit. Outcomes will be compared to the Intervention group at the end of the study.
- interventionNames
- Other: eSSET-CINV
Primary outcomes (4)
- measure
- Symptom Severity Change Over Time
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Men and women age 65 and older * newly diagnosed with any cancer * treatment with any chemotherapeutic agent with a moderate to severe emetic potential (on a 3- or 4- week cycle) * proficient in English * have a telephone. Exclusion Criteria: * Patients with previous diagnosis and treatment for cancer * advanced or end stage disease with a palliative intent * visually or hearing impaired.
References
Publications (0)
Data not yet available
No reference posted for this study.